Drugs in R&D
Description
Drugs in R&D publishes original research and reviews from all phases of drug development and on the clinical use of drugs following approval.
Articles published in Drugs in R&D may be accompanied by plain language summaries, to assist patients, caregivers and others in understanding important medical advances.
The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.
Manuscripts submitted to the journal for publication will be subject to a $US3,000 / €2,200 article processing charge (APC) upon acceptance. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.
The journal will consider fee discounts for developing countries and this is decided on a case by case basis.
Latest Articles
-
Original Research Article
A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment
Mark Allison, Cecilia Hale (April 2018)
-
Original Research Article
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
Jordi Guitart, María Isabel Vargas, Vicente De Sanctis, Jordi Folch… (March 2018)
-
Review Article
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
Manon Auffret, Sophie Drapier, Marc Vérin (March 2018)

- Available 1999 - 2018
- Volumes 18
- Issues 88
- Articles 963
- Open Access 316 Articles
Stay up to Date
Find a Volume or Issue
- Journal Title
- Drugs in R&D
- Coverage
- Volume 1 / 1999 - Volume 18 / 2018
- Print ISSN
- 1174-5886
- Online ISSN
- 1179-6901
- Publisher
- Springer International Publishing
- Additional Links
Continue reading...
To view the rest of this content please follow the download PDF link above.